Skip to main content
Top
Published in: BMC Neurology 1/2022

Open Access 01-12-2022 | Vasculitis | Case report

Amyloid-β related angiitis presenting as eosinophilic meningitis: a case report

Authors: Jeremy A. Tanner, Megan B. Richie, Cathryn R. Cadwell, Amity Eliaz, Shannen Kim, Zeeshan Haq, Nailyn Rasool, Maulik P. Shah, Elan L. Guterman

Published in: BMC Neurology | Issue 1/2022

Login to get access

Abstract

Background

Eosinophilic meningitis is uncommon and often attributed to infectious causes.

Case presentation

We describe a case of a 72-year-old man who presented with subacute onset eosinophilic meningitis, vasculitis, and intracranial hypertension with progressive and severe neurologic symptoms. Brain MRI demonstrated multifocal strokes and co-localized right temporo-parieto-occipital vasogenic edema, cortical superficial siderosis, and diffuse leptomeningeal enhancement. He ultimately underwent brain biopsy with immunohistochemical stains for amyloid-β and Congo red that were extensively positive in the blood vessel walls and in numerous diffuse and neuritic parenchymal confirming a diagnosis of amyloid-β related angiitis. He was treated with immunosuppression with clinical stabilization.

Conclusions

Amyloid-β related angiitis is an underrecognized cause of eosinophilic meningitis that can present fulminantly and is typically responsive to immunosuppression. The presence of eosinophils may provide additional clues to the underlying pathophysiology of amyloid-β related angiitis.
Literature
2.
go back to reference Scolding NJ, Joseph F, Kirby PA, et al. Abeta-related angiitis: primary angiitis of the central nervous system associated with cerebral amyloid angiopathy. Brain J Neurol. 2005;128:500–15.CrossRef Scolding NJ, Joseph F, Kirby PA, et al. Abeta-related angiitis: primary angiitis of the central nervous system associated with cerebral amyloid angiopathy. Brain J Neurol. 2005;128:500–15.CrossRef
3.
go back to reference Salvarani C, Hunder GG, Morris JM, Brown RD, Christianson T, Giannini C. Aβ-related angiitis: comparison with CAA without inflammation and primary CNS vasculitis. Neurology. 2013;81:1596–603.PubMedPubMedCentralCrossRef Salvarani C, Hunder GG, Morris JM, Brown RD, Christianson T, Giannini C. Aβ-related angiitis: comparison with CAA without inflammation and primary CNS vasculitis. Neurology. 2013;81:1596–603.PubMedPubMedCentralCrossRef
4.
go back to reference Fountain NB, Eberhard DA. Primary angiitis of the central nervous system associated with cerebral amyloid angiopathy: report of two cases and review of the literature. Neurology. 1996;46:190–7.PubMedCrossRef Fountain NB, Eberhard DA. Primary angiitis of the central nervous system associated with cerebral amyloid angiopathy: report of two cases and review of the literature. Neurology. 1996;46:190–7.PubMedCrossRef
5.
go back to reference Hirano K, Fukae J, Hieda S, Fujimaki M, Ishii H, Tsuboi Y, et al. Eosinophilic meningitis caused by primary angiitis of the central nervous system. Intern Med Tokyo Jpn. 2013;52:1393–6.CrossRef Hirano K, Fukae J, Hieda S, Fujimaki M, Ishii H, Tsuboi Y, et al. Eosinophilic meningitis caused by primary angiitis of the central nervous system. Intern Med Tokyo Jpn. 2013;52:1393–6.CrossRef
6.
go back to reference Chu S, Xu F, Su Y, Chen H, Cheng X. Cerebral Amyloid Angiopathy (CAA)-related inflammation: comparison of inflammatory CAA and amyloid-β-related Angiitis. J Alzheimers Dis. 2016;51:525–32.PubMedCrossRef Chu S, Xu F, Su Y, Chen H, Cheng X. Cerebral Amyloid Angiopathy (CAA)-related inflammation: comparison of inflammatory CAA and amyloid-β-related Angiitis. J Alzheimers Dis. 2016;51:525–32.PubMedCrossRef
7.
go back to reference Corovic A, Kelly S, Markus HS. Cerebral amyloid angiopathy associated with inflammation: a systematic review of clinical and imaging features and outcome. Int J Stroke. 2018;13:257–67.PubMedCrossRef Corovic A, Kelly S, Markus HS. Cerebral amyloid angiopathy associated with inflammation: a systematic review of clinical and imaging features and outcome. Int J Stroke. 2018;13:257–67.PubMedCrossRef
8.
go back to reference Moussaddy A, Levy A, Strbian D, Sundararajan S, Berthelet F, Lanthier S. Inflammatory cerebral amyloid angiopathy, amyloid-β-related Angiitis, and primary Angiitis of the central nervous system: similarities and differences. Stroke. 2015;46:210.CrossRef Moussaddy A, Levy A, Strbian D, Sundararajan S, Berthelet F, Lanthier S. Inflammatory cerebral amyloid angiopathy, amyloid-β-related Angiitis, and primary Angiitis of the central nervous system: similarities and differences. Stroke. 2015;46:210.CrossRef
9.
go back to reference Regenhardt RW, Thon JM, Das AS, et al. Association Between Immunosuppressive Treatment and Outcomes of Cerebral Amyloid Angiopathy–Related Inflammation. JAMA Neurol. 2020;77:1–10.PubMedCentralCrossRef Regenhardt RW, Thon JM, Das AS, et al. Association Between Immunosuppressive Treatment and Outcomes of Cerebral Amyloid Angiopathy–Related Inflammation. JAMA Neurol. 2020;77:1–10.PubMedCentralCrossRef
10.
go back to reference Agarwal N, Carare RO. Cerebral vessels: an overview of anatomy, physiology, and role in the drainage of fluids and solutes. Front Neurol. 2020;11:611485.PubMedCrossRef Agarwal N, Carare RO. Cerebral vessels: an overview of anatomy, physiology, and role in the drainage of fluids and solutes. Front Neurol. 2020;11:611485.PubMedCrossRef
11.
go back to reference Keable A, Fenna K, Yuen HM, et al. Deposition of amyloid β in the walls of human leptomeningeal arteries in relation to perivascular drainage pathways in cerebral amyloid angiopathy. Biochim Biophys Acta. 2016;1862:1037–46.PubMedPubMedCentralCrossRef Keable A, Fenna K, Yuen HM, et al. Deposition of amyloid β in the walls of human leptomeningeal arteries in relation to perivascular drainage pathways in cerebral amyloid angiopathy. Biochim Biophys Acta. 2016;1862:1037–46.PubMedPubMedCentralCrossRef
12.
go back to reference Charidimou A, Gang Q, Werring DJ. Sporadic cerebral amyloid angiopathy revisited: recent insights into pathophysiology and clinical spectrum. J Neurol Neurosurg Psychiatry. 2012;83:124–37.PubMedCrossRef Charidimou A, Gang Q, Werring DJ. Sporadic cerebral amyloid angiopathy revisited: recent insights into pathophysiology and clinical spectrum. J Neurol Neurosurg Psychiatry. 2012;83:124–37.PubMedCrossRef
13.
go back to reference Piazza F, Greenberg SM, Savoiardo M, et al. Anti-amyloid β autoantibodies in cerebral amyloid angiopathy-related inflammation: implications for amyloid-modifying therapies. Ann Neurol. 2013;73:449–58.PubMedCrossRef Piazza F, Greenberg SM, Savoiardo M, et al. Anti-amyloid β autoantibodies in cerebral amyloid angiopathy-related inflammation: implications for amyloid-modifying therapies. Ann Neurol. 2013;73:449–58.PubMedCrossRef
14.
go back to reference Bogner S, Bernreuther C, Matschke J, et al. Immune activation in amyloid-β-related angiitis correlates with decreased parenchymal amyloid-β plaque load. Neurodegener Dis. 2014;13:38–44.PubMed Bogner S, Bernreuther C, Matschke J, et al. Immune activation in amyloid-β-related angiitis correlates with decreased parenchymal amyloid-β plaque load. Neurodegener Dis. 2014;13:38–44.PubMed
15.
go back to reference Sperling R, Salloway S, Brooks DJ, et al. Amyloid-related imaging abnormalities in patients with Alzheimer’s disease treated with bapineuzumab: a retrospective analysis. Lancet Neurol. 2012;11:241–9.PubMedPubMedCentralCrossRef Sperling R, Salloway S, Brooks DJ, et al. Amyloid-related imaging abnormalities in patients with Alzheimer’s disease treated with bapineuzumab: a retrospective analysis. Lancet Neurol. 2012;11:241–9.PubMedPubMedCentralCrossRef
16.
go back to reference Haeberlein SB, Chen T, Wu S, et al. EMERGE and ENGAGE topline results: two phase 3 studies to evaluate Aducanumab in patients with early Alzheimer’s disease. Developments in clinical trials and cognitive assessment. Alzheimers Dement. 2020;16:e047259 Presented at advances in Alzheimer’s and Parkinson’s therapies: an AAT-AD/PD focus meeting. Vienna, April 2-5.CrossRef Haeberlein SB, Chen T, Wu S, et al. EMERGE and ENGAGE topline results: two phase 3 studies to evaluate Aducanumab in patients with early Alzheimer’s disease. Developments in clinical trials and cognitive assessment. Alzheimers Dement. 2020;16:e047259 Presented at advances in Alzheimer’s and Parkinson’s therapies: an AAT-AD/PD focus meeting. Vienna, April 2-5.CrossRef
17.
go back to reference Carmona-Iragui M, Fernández-Arcos A, Alcolea D, et al. Cerebrospinal fluid anti-amyloid-β autoantibodies and amyloid PET in cerebral amyloid angiopathy-related inflammation. J Alzheimers Dis. 2016;50:1–7.PubMedCrossRef Carmona-Iragui M, Fernández-Arcos A, Alcolea D, et al. Cerebrospinal fluid anti-amyloid-β autoantibodies and amyloid PET in cerebral amyloid angiopathy-related inflammation. J Alzheimers Dis. 2016;50:1–7.PubMedCrossRef
18.
go back to reference Sarkar C, Lakhtakia R, Gill SS, Sharma MC, Mahapatra AK, Mehta VS. Chronic subdural haematoma and the enigmatic eosinophil. Acta Neurochir. 2002;144:983–8 discussion 988.PubMedCrossRef Sarkar C, Lakhtakia R, Gill SS, Sharma MC, Mahapatra AK, Mehta VS. Chronic subdural haematoma and the enigmatic eosinophil. Acta Neurochir. 2002;144:983–8 discussion 988.PubMedCrossRef
20.
go back to reference Auriel E, Charidimou A, Gurol ME, et al. Validation of clinicoradiological criteria for the diagnosis of cerebral amyloid angiopathy-related inflammation. JAMA Neurol. 2016;73:197–202.PubMedCrossRef Auriel E, Charidimou A, Gurol ME, et al. Validation of clinicoradiological criteria for the diagnosis of cerebral amyloid angiopathy-related inflammation. JAMA Neurol. 2016;73:197–202.PubMedCrossRef
21.
go back to reference Renard D, Wacongne A, Ayrignac X, et al. Cerebrospinal fluid Alzheimer’s disease biomarkers in cerebral amyloid angiopathy-related inflammation. J Alzheimers Dis. 2016;50:759–64.PubMedPubMedCentralCrossRef Renard D, Wacongne A, Ayrignac X, et al. Cerebrospinal fluid Alzheimer’s disease biomarkers in cerebral amyloid angiopathy-related inflammation. J Alzheimers Dis. 2016;50:759–64.PubMedPubMedCentralCrossRef
23.
go back to reference Baron J-C, Farid K, Dolan E, et al. Diagnostic utility of amyloid PET in cerebral amyloid angiopathy-related symptomatic intracerebral hemorrhage. J Cereb Blood Flow Metab. 2014;34:753–8.PubMedPubMedCentralCrossRef Baron J-C, Farid K, Dolan E, et al. Diagnostic utility of amyloid PET in cerebral amyloid angiopathy-related symptomatic intracerebral hemorrhage. J Cereb Blood Flow Metab. 2014;34:753–8.PubMedPubMedCentralCrossRef
24.
go back to reference Ossenkoppele R, Jansen WJ, Rabinovici GD, et al. Prevalence of amyloid PET positivity in dementia syndromes: a meta-analysis. JAMA. 2015;313:1939–49.PubMedPubMedCentralCrossRef Ossenkoppele R, Jansen WJ, Rabinovici GD, et al. Prevalence of amyloid PET positivity in dementia syndromes: a meta-analysis. JAMA. 2015;313:1939–49.PubMedPubMedCentralCrossRef
25.
go back to reference DiFrancesco JC, Brioschi M, Brighina L, et al. Anti-Aβ autoantibodies in the CSF of a patient with CAA-related inflammation: a case report. Neurology. 2011;76:842–4.PubMedCrossRef DiFrancesco JC, Brioschi M, Brighina L, et al. Anti-Aβ autoantibodies in the CSF of a patient with CAA-related inflammation: a case report. Neurology. 2011;76:842–4.PubMedCrossRef
26.
go back to reference Calabrese LH, Mallek JA. Primary angiitis of the central nervous system. Report of 8 new cases, review of the literature, and proposal for diagnostic criteria. Medicine (Baltimore). 1988;67:20–39.CrossRef Calabrese LH, Mallek JA. Primary angiitis of the central nervous system. Report of 8 new cases, review of the literature, and proposal for diagnostic criteria. Medicine (Baltimore). 1988;67:20–39.CrossRef
27.
go back to reference Giannini C, Salvarani C, Hunder G, Brown RD. Primary central nervous system vasculitis: pathology and mechanisms. Acta Neuropathol (Berl). 2012;123:759–72.CrossRef Giannini C, Salvarani C, Hunder G, Brown RD. Primary central nervous system vasculitis: pathology and mechanisms. Acta Neuropathol (Berl). 2012;123:759–72.CrossRef
28.
go back to reference Ng DW, Magaki S, Terashima KH, Keener AM, Salamon N, Karnezis S, et al. Amyloid-β-related angiitis: a report of 2 cases with unusual presentations. Hum Pathol. 2017;64:191–7.PubMedCrossRef Ng DW, Magaki S, Terashima KH, Keener AM, Salamon N, Karnezis S, et al. Amyloid-β-related angiitis: a report of 2 cases with unusual presentations. Hum Pathol. 2017;64:191–7.PubMedCrossRef
Metadata
Title
Amyloid-β related angiitis presenting as eosinophilic meningitis: a case report
Authors
Jeremy A. Tanner
Megan B. Richie
Cathryn R. Cadwell
Amity Eliaz
Shannen Kim
Zeeshan Haq
Nailyn Rasool
Maulik P. Shah
Elan L. Guterman
Publication date
01-12-2022
Publisher
BioMed Central
Published in
BMC Neurology / Issue 1/2022
Electronic ISSN: 1471-2377
DOI
https://doi.org/10.1186/s12883-022-02638-w

Other articles of this Issue 1/2022

BMC Neurology 1/2022 Go to the issue